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Abstract
Background: Much is known about how genes regulated by nuclear receptors (NRs) are switched on in the presence of a
ligand. However, the molecular mechanism for gene down-regulation by liganded NRs remains a conundrum. The
interaction between two zinc-finger transcription factors, Nuclear Receptor and GATA, was described almost a decade ago
as a strategy adopted by the cell to up- or down-regulate gene expression. More recently, cell-based assays have shown that
the Zn-finger region of GATA2 (GATA2-Zf) has an important role in down-regulation of the thyrotropin gene (TSHb)b y
liganded thyroid hormone receptor (TR).
Methodology/Principal Findings: In an effort to better understand the mechanism that drives TSHb down-regulation by a
liganded TR and GATA2, we have carried out equilibrium binding assays using fluorescence anisotropy to study the
interaction of recombinant TR and GATA2-Zf with regulatory elements present in the TSHb promoter. Surprisingly, we
observed that ligand (T3) weakens TR binding to a negative regulatory element (NRE) present in the TSHb promoter. We
also show that TR may interact with GATA2-Zf in the absence of ligand, but T3 is crucial for increasing the affinity of this
complex for different GATA response elements (GATA-REs). Importantly, these results indicate that TR complex formation
enhances DNA binding of the TR-GATA2 in a ligand-dependent manner.
Conclusions: Our findings extend previous results obtained in vivo, further improving our understanding of how liganded
nuclear receptors down-regulate gene transcription, with the cooperative binding of transcription factors to DNA forming
the core of this process.
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Introduction
The molecular mechanisms that control gene expression are still
emerging, revealing regulatory circuits that permit a finely tuned
transitionbetweenactivationand repression.We arenowbeginning
to understand how genes are switched on and off, regulating the
transcriptional activity, however the subtleties of protein-DNA
interaction that drive up- or down-regulation remain elusive,
especially in what concerns genes under nuclear receptor control.
The human nuclear receptor (NR) gene superfamily comprises
transcription factors that modulate gene expression in a ligand-
dependent manner. They have an important role in growth,
development and homeostasis by regulating the expression of
many genes in response to small, fat-soluble molecules, such as
thyroid hormones, steroids and vitamin D. The family is mainly
characterized by two domains, a highly conserved DNA-binding
domain (DBD) and a less well conserved ligand-binding domain
(LBD).
In general, NRs can regulate gene expression by binding
directly or indirectly to specific sequences in the promoter of target
genes. Moreover, they can also act by interfering with transcrip-
tional complex formation in a DNA-independent manner. The
classical mechanism of NR activity proceeds via direct DNA
binding at hormone response elements (HRE) in the promoter
region of target genes. The simplest current model suggests that
NRs in a homo or heterodimer form, typically complexed with
retinoid X receptor (RXR), bind directly to an HRE. In the
absence of DNA, NRs were observed in monomeric, dimeric and
tetrameric forms, the latter dissociating into dimers in the presence
of DNA and/or cognate ligands [1,2].
It has however become clear that an important regulatory
activity of nuclear receptors involves repression of genes in
response to regulatory ligands [3–5]. Indeed, microarray-based
gene expression profiling suggests that, for example, in the liver,
the thyroid hormone T3 down-regulates more than twice as many
genes as it activates [6]. However, the mechanism used by a
ligand-bound NR leading to repression of transcription is still a
subject of contention [7].
The term ‘‘negative regulation’’ has been used in the context
of nuclear receptor signalling to describe the ability of NRs to
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potential ‘‘negative response element’’ or ‘‘negative regulatory
element (NRE)’’. Early studies found that thyroid hormone
receptor down-regulates transcription of thyrotropin a (TSHa)
[8] and the thyrotropin b (TSHb) gene [9] in response to thyroid
hormone. These studies identified a so-called negative thyroid
hormone response element (nTRE) downstream of the TATA box
of the TSHa gene and in the first exon of TSHb gene.
In fact, the sequence in the promoter of TSHb gene responsible
for mediating inhibition by T3/TR contains a single half-site-like
sequence (GGGTCA) and is denoted as nTRE [9–14] or NRE
[15,16] (Fig. 1a).
Thus these early models of down-regulation by nuclear
receptors and other later studies [17] concluded that the liganded
receptor was binding directly to DNA and interfering with the
process of transcriptional activation that would normally take
place in the absence of liganded nuclear receptor protein.
Some years later the requirement for DNA-binding activity in
TR for the negative regulation of TSH by thyroid hormone was
demonstrated in vivo. A ‘‘knock in’’ mouse harbouring a TRb
mutant defective in DNA binding was studied [18]. In these mice,
thyroid hormone fails to suppress TSH gene transcription,
supporting the conclusion that negative regulation of the TSH
gene requires DNA binding by TR. Therefore, the direct bind-
ing to DNA seems to be one of the strategies adopted by nuclear
receptors for transcriptional down-regulation. In subsequent
years, however, other mechanisms used by liganded NR to
down-regulate target genes have been reported, suggesting that
NR does not require DNA-binding to down-regulate gene
transcription.
Several models have been proposed to explain the crosstalk
between NRs and general transcription factors (TF) to drive
transcriptional repression. For example, applying different in vivo
strategies, a model was proposed for repression by GR which
involves tethering, or direct binding of the receptor to an other
transcription factor [19], notably AP1 [20] and NF-kB [21]. In
this trans-repression mechanism, just one transcription factor
binds to the DNA, either a NR or a general TF, without the
requirement of two different binding sites. Although subject to
controversy, the DBD of nuclear receptors seems to be required
for gene trans-repression [22–24].
The crosstalk between TFs, like nuclear receptors and GATA,
has been reported as crucial in controlling gene expression [25–
30]. Each of the six identified GATA proteins contains a highly
conserved DNA-binding domain consisting of two zinc fingers.
These two zinc fingers have been shown to bind directly to the
DNA sequence element (A or T) GATA (A or G) [31], although
the carboxy-terminal zinc finger is sufficient for site-specific
binding [32].
More recently, an intriguing hypothesis explaining the mecha-
nism of the negative regulation of the TSHb gene suggests a cross
talk between TR with GATA2 [16]. Using a highly sensitive
reporter assay in a nonpituitary CV1 (kidney-derived) cell co-
transfected with GATA2, Pit1 (another transcription factor) and/or
TR, Matsushita et al. showed that GATA2 alone could activate the
TSHbpromoter,and thistransactivation wasrepressedbyliganded
TR [16]. They also demonstrated in vivo, by co-expression in 293T
cells, and in vitro (GST pull-down assay) that the Zn-finger region of
GATA2 (GATA2-Zf) interacts with the TR DBD in a ligand-
independent manner, and this complex was essential for negative
regulation by thyroid hormone. It was proposed that TR interacts
with GATA2-Zf on a GATA response element (GATA-RE)
present in the TSHb promoter [16]. Furthermore, this study
demonstrated in CV1 cells that the negative regulation by liganded
TR was preserved after complete destruction of the NRE. Thus,
contrary to previous study [15] it was suggested that the NRE,
which contains a single half-site like sequence (GGGTCA), is not
required for the TSHb down-regulation.
The study of the TR-GATA2 complex on DNA is particularly
attractive because it is potentially the primary complex assembled
on the TSHb promoter triggered by T3 binding to TR. In addition,
the interaction of GATA2 with TR occurs through the highly
conserved zinc-finger DNA binding domains. Taken together, the
understanding of how T3 signalling is propagated through the TR
DBDs to GATA2-Zn and DNA would provide new insights into the
mechanismofgene down-regulationbya ligandednuclear receptor.
Therefore, in an effort to better understand the mechanism
responsible for TSHb down-regulation mediated by liganded TR-
GATA2 complex, we have carried out equilibrium binding assays
to investigate the ability of TRb1 and GATA2-Zf to bind to
different response elements in TSHb promoter sequence.
Results
Thyroid Hormone Receptor (TR) on negative regulatory
element in TSHb promoter (NRE)
To enable a better understanding of the dynamic of the TR-
NRE complex, we measured the binding affinity of TRb1 DL for
the fluorophore-labelled reporter sequence using direct fluores-
cence anisotropy titrations. Fluorescence anisotropy, based on the
property of fluorescent molecules to retain the polarization of the
excitation light, reflects the tumbling rate of molecules in solution.
Figure 1. Thyroid Hormone Receptor (TR) on negative regula-
tory element (NRE) in TSHb promoter. A – Schematic structure of
the TSHb promoter: The binding sites for GATA2, TATA box, and
reported NRE. B – Fluorescence anisotropy curve of binding TR DL
(black dots), T3/TR DL (white dots) and T3/TR DL+RXR DL to
fluorophore-labelled sequence TSH NRE (black triangles). Protein
titrations were made from 1 to 10000nM on 10nM of fluorescence.
doi:10.1371/journal.pone.0012628.g001
TR and GATA2 on TSH Promoter
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formed is larger and tumbles more slowly than the unbound
oligonucleotide.
Therefore, we designed the anisotropy binding titration assays
using the NRE present in the TSHb promoter (TSH NRE) [15] to
detect the TRb1 binding to this negative response element in
terms of dissociation constants (Kds). A Hill coefficient ‘‘n’’ higher
than unity is indicative of a high degree of cooperativity, meaning
that the binding of the first monomer facilitates the binding of the
second monomer.
It has been reported that TR may bind to DNA as a monomer,
homodimer or heterodimer form with RXR [33–35], depending
on the architecture of the TRE. To verify the role of RXRa in
TRb1-TSH NRE complex, we also titrated in TR-RXR complex.
We found that in the absence of T3, TRb1 cooperatively binds
to TSH NRE with a relatively high affinity, Kd of 316+/229 nM
(n=3.5). The Hill coefficient (n) of 3 rules out a simple monomer
interaction and implies a dimerization energetically coupled to
DNA binding in the nanomolar range. Surprisingly, we observed
that liganded TRb1 bound to TSH NRE (Kd=1180+/2226 nM;
n=1.7) much weaker than the unliganded TRb1. Importantly,
liganded TRb1 also binds to TSH NRE in a cooperative manner
(Fig. 1b) (Table 1).
We observed that the T3/TRb1-RXRa complex bound to
NRE with a Kd of 720+/219 nM (n=1.8), however T3/TRb1-
RXRa binding was still 2 fold weaker than the unliganded TRb1
binding.
Thyroid Hormone Receptor on positive regulatory
element (DR4)
In order to compare our findings on NRE with a canonical
positive response element (pTRE), we designed new isothermal
binding assays using DR4 (direct repeats spaced by 4 nucleotides)
to detect the TRb1 DL preferences for this pTRE in terms of
dissociation constants (Kds).
We showed that unliganded TRb1 DL bound weakly to DR4
(Kd=2044+/2266 nM; n=1.0). In presence of T3, TRb1
revealed a somewhat similar affinity for DR4 (Kd=1975+/
2295 nM; n=2.0), however, this binding showed a stronger
tendency to form homodimers. In previous studies [36,37], we
observed that liganded TRb1 in complex with RXRa binds more
strongly to DR4 in a clearly cooperative binding (Kd=39.4+/
22.2 nM; n=3.7) (Fig. 2) (Table 1). Therefore, it is shown that the
cooperation between RXRa DL and TRb1 DL increases the
affinity of the protein complex for the DR4 by a magnitude of 50
fold, different of RXRa DL on the NRE.
In another study, we observed that unliganded TR strongly
bound (KD=63 nM) to a longer RE containing DR4 in a
cooperative way [38], suggesting TR may be better accommo-
dated when this RE has a longer fragment flanking the DR4. Also,
the 4 nucleotides between the direct repeats may have an impor-
tant role for the binding affinity of TR, since they were different
from the short DR4 we studied here.
TR DBD binding to GATA2 - Zinc finger
It had previously been proposed that the negative regulation of
TSHb gene by thyroid hormone was mainly due to the interaction
between TR and GATA2 [16]. It was demonstrated that TR DBD
interacts with GATA2-Zf in a T3-independent manner. In this
model, a TR-GATA2 is recruited to a GATA-RE to mediate the
TSHb down-regulation.
To investigate the direct interaction of TR DBD with ZnFinger
GATA2, we used GST-TR DBD to pull down the His-tagged
GATA2-Zf (data not shown). To further characterize the potential
complex, TR DBD-GATA2-Zf in the presence of a GATA-RE
from the TSHb promoter was subjected to size exclusion puri-
fication by gel filtration. However, we observed that the two
proteins do not co-migrate (data not shown). The electrophoretic
analysis of fractions purified from gel filtration shows that both
proteins can bind to the DNA, but it was inconsistent with a
heterodimer formation of GATA2-ZF with TR DBD on the DNA
(Fig. 3a).
In another attempt to isolate the heterodimer complex, GST-
TR DBD and His tag GATA2-Zf plus DNA were purified using
an anion exchange column. Here, we found that the majority of
the complex falls apart during this purification method (Fig. 3b
and 3c).
To determine the precise binding affinity of TR for GATA2-Zf
and to verify the importance of the ligand binding domain of TR
in the complex formation, we performed fluorescence anisotropy
assays with fluorophore-labelled GATA2-Zf and non-labelled
recombinant TRs, one is TR DBD-LBD which has the DNA
binding domain and ligand binding domain (TR DL) and the
other is TR DBD which has just the DNA binding domain. TR
DL bound to GATA2-Zf with a Kd of 1173+/285 nM (n=1.6),




Protein Kd (nM) Hill coef. (n) Kd (nM) Hill coef. (n)
TR DBD-LBD 316629 3.560.1 20446266 160.1
T3/TR DBD-LBD 11806226 1.760.4 19756295 260.4
T3/TR DBD-LBD+RXR 720619 1.860.1 39.462.2 3.761
Unliganded or liganded TRb1 DL (TR DBD-LBD) and liganded TRb1D L +RXRa
complex to fluorophore-labelled DNA (DR4). N is the Hill coefficient.
doi:10.1371/journal.pone.0012628.t001
Figure 2. Thyroid Hormone Receptor on positive regulatory
element (DR4). Fluorescence anisotropy curve of binding TR DL (black
dots), T3/TR DL (white dots) and T3/TR DL+RXR DL to fluorophore-
labelled sequence DR4 (black triangles). Protein titrations were made
from 1 to 10000nM on 10nM of fluorescence labelled DR4.
doi:10.1371/journal.pone.0012628.g002
TR and GATA2 on TSH Promoter
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(Fig. 4). Apparently, the LBD also plays a role in this interaction,
since the TR DL bound slightly stronger to GATA2-Zf.
TR DL and GATA2-Zf on GATA-RE from TSHb promoter
Cell-based assays had previously been shown that T3/TR might
interact with GATA2-Zf on a GATA2 response element in the
TSHb promoter, leading to down-regulation [16].
To further investigate whether the unliganded TR and GATA2
bind to DNA in a cooperative manner, we performed new
fluorescence anisotropy assays with TR DL, GATA2-Zf and TSH
GATA-RE (Fig. 5) (Table 2). We observed that unliganded TR
DL showed no detectable binding to TSH GATA-RE. GATA2-Zf
alone bound to TSH GATA-RE with a Kd of 688+/239 nM
(n=3.1). The association between unliganded TR DL and
GATA2-Zf showed weaker binding to TSH GATA-RE, suggest-
ing that unliganded TR inhibits GATA2 binding to DNA.
To verify the specificity of GATA2-Zf binding, we used a
canonical GATA-RE in the new fluorescence anisotropy assays
(Fig. 6) (Table 2). As expected, GATA2-Zf bound strongly to
Figure 3. TR DBD binding to GATA2 - Zinc finger. A –
Electrophoretic analysis of fractions purified from gel filtration: TR
DBD, TR DBD+GATAZf and GATA2-Zf bound to TSH GATA-RE. The
proteins alone or heterodimer TR DBD-GATA2-Zf was prepared mixing
equimolar quantities (100uM) of each protein plus DNA and loaded in a
gel filtration column. Fractions of the peaks eluted from gel filtration
containing TR DBD-DNA, GATA2-DNA, or TR DBD- GATA2-Zf-DNA were
run in agarose gel 1.3% with 0.56TBE. Gel was stained with Ethidium
bromide and analysed on the UV light. B and C – Purification of GST-TR
DBD and his-GATA2-Zf in presence of TSH GATA-RE using ion exchange
column. The complex TR DBD+GATA2-Zf+TSH GATA-RE was applied
onto an ion exchange column, which eluted as two peaks, one
corresponds to GST TR DBD and another corresponds to GATA2-Zf. The
SDS-page presents each peak after purification. In lane 1 shows the
molecular weight markers; lane 2 shows the two proteins (GST-TR
DBD+his-GATA2-Zf) co-eluted; lanes 3 to 6 corresponds to GST-TR DBD
elution; and lines 7 to 11 corresponds to GATA2-Zf elution.
doi:10.1371/journal.pone.0012628.g003
Figure 4. TR DBD and DL binding to GATA2 - Zinc finger.
Fluorescence anisotropy curve of association of unliganded TR DL and
TR DBD to fluorescein-labeled GATA2-Zf (black dots). In these curves, TR
DL and TR-DBD were titrated, separately, on 10nM fluorescent probed
GATA2-Zf, in a concentration range between 1 to 10.000nM.
doi:10.1371/journal.pone.0012628.g004
Figure 5. TR DL and GATA2-Zf on TSH GATA-RE from TSHb
promoter. Fluorescence anisotropy curve of binding unliganded TR DL
(black dots), GATA-2 (white dots), unliganded TR DL+GATA2-Zf complex
(inverted black triangles), T3/TR DL+GATA2-Zf (black triangles) and T3/
TR DL (grey triangles) to 10 nM of fluorophore-labelled sequence TSH
GATA-RE DNA. All curves were made separately; being each protein
titrated on the DNA, in a concentration range of 1 to 10000nM.
doi:10.1371/journal.pone.0012628.g005
TR and GATA2 on TSH Promoter
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and no Kd could be determined. Again, the association between
the two proteins, unliganded TR DL and GATA2-Zf, showed
weaker affinity for GATA-RE, suggesting again that unliganded
TR DL may disturb the GATA2-Zf binding to GATA-RE.
In order to examine in detail the effect of T3 on TR-GATA2
binding to DNA, we performed new experiments using a
canonical GATA-RE and also the TSH GATA-RE. To our
surprise, T3/TR DL-GATA-Zf showed much higher affinity for
both GATA-RE, TSH GATA-RE (Kd=38.6+/27.9 nM; n=1)
and GATA-RE (Kd=139.7+/230 nM; n=1) than the complex
did in the absence of T3 (Fig. 5 and 6 respectively) (Table 2).
Liganded TR DL alone showed very weak binding to both
GATA-REs, and we were unable to determine the precise Kd.
Discussion
The mechanisms used by the cell to down-regulate gene
transcription by liganded nuclear hormone receptors remains a
conundrum in the field.
Lessons from bacteria have led to the view that higher-order
complexes permit cooperative binding to both adjacent and non-
adjacent operator sites. The switch between transcriptional
activation and repression will depend on the formation of these
higher-order protein-DNA complexes [39].
However, identification of many components involved in
activation and repression of gene transcription has led us to build
several models to explain how gene expression takes place in a
specific cell environment. In fact, the control of the cellular
concentration of transcriptional regulators appears to define and
modulate gene expression [40].
Cell-based assays have suggested that GATA2 may interact with
TR to down-regulate TSHb gene transcription [16]. In trying to
map the contact surface responsible for this interaction, it was
proposed that the Zn-finger region of GATA2 interacts with the TR
DBD ina T3-independent manner, itbeing sufficient to driveTSHb
down-regulation. The authors suggested that TR would bind to
DNA via GATA2 on a GATA response element present in the
TSHb promoter. Challenging a previous study [15], itwassuggested
that a NRE is not required for this TSHb down-regulation.
T3 weakens the binding of TR to the NRE
As a means to address the conflicting data about the significance
of NRE for TSHb down-regulation by T3, we studied the TR
binding affinity for the NRE present in the TSHb promoter.
We found that unliganded TR binds tightly to DNA, and, we
show for the first time that T3 weakens this interaction (4 fold)
without affecting the cooperative nature of binding. Interestingly,
RXR did increase the affinity of the liganded TR for the NRE.
However, T3/TR-RXR binding was still 2 fold weaker than the
unliganded TR binding. This suggests that RXR does not have a
major role in the TSHb regulation. This finding is in agreement
with another study that demonstrated that RXR inhibited TR-
NRE complex formation in vitro [15]. Also, it is in accordance with
the studies on TR and RXR knockout mice, which suggest that
RXR is dispensable for TSH regulation [41].
Previous studies have shown that T3 disrupts the TR dimer
binding and increases the intensity of monomer binding to a TRE
in a dose-dependent manner. This disruption of the TR dimer
binding by T3 was believed to occur on a TRE formed by a
direct repeat and not on a palindromic TRE [35]. Our data
present evidence that the binding affinity of TR for DNA might
be affected by modifications that occur in the LBD after ligand
binding, without disrupting the oligomerization state of the
protein. The structure of the full-length PPAR-RXR on DNA
shows that the LBD of PPAR interacts with both the LBD and
DBD of RXR and also that the hinge region makes an extensive
DNA interaction. In addition, it was shown that PPAR LBD
makes electrostatic interactions with DNA [42]. Taken together,
it is plausible that the TR LBD plays a decisive role in the ability
of the receptor to bind DNA. However, more structural
information at atomic level resolution is needed to explain the
precise mechanism by which T3 weakens the binding of TR to
DNA.
Using mostly band shift and transient transfections assays
several groups have suggested that TR interacts with an inhibitory
element immediately downstream of the transcription start site,
and that this interaction is important for TSHb gene down-
regulation mediated by T3 [9–15,17,43].













TR DBD-LBD ND* ND* ND* ND*
T3/TR DBD-LBD ND* ND* ND* ND*
GATA2-Zf 688.8638.7 3.160.4 14.961.5 1.360.4
GATA2-Zf+TR DBD-LBD 32576160.9 3.360.4 1707694.6 1.760.1
GATA2-Zf+T3/TR DBD-LBD 38.667.9 160.2 139.7629.8 160.2
Unliganded or liganded TRb1 DL (DBD-LBD), GATA2-Zf and unliganded or
liganded TR DL+GATA2-Zf complex to fluorophore-labelled DNA (TSH GATA-RE
and canonical GATA-RE). N is the Hill coefficient. ND means non determined.
doi:10.1371/journal.pone.0012628.t002
Figure 6. TR DL and GATA2-Zf on canonical GATA-RE.
Fluorescence anisotropy curve of binding unliganded TR DL (black
dots), GATA2-Zf (white dots), unliganded TR DL+GATA2-Zf complex
(inverted black triangles), T3/TR DL+GATA2-Zf (black triangles) and T3/
TR DL (grey triangles) to 10nM of fluorophore-labelled sequence GATA-
RE. All curves were made separately; being each protein titrated on the
DNA, in a concentration range of 1 to 10000nM.
doi:10.1371/journal.pone.0012628.g006
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proteins that bind to the NRE can be detected on a solid bead
matrix, it was suggested that TRb1 is recruited to NRE beads in a
ligand-dependent manner [15]. It was also suggested that histone
deacetylase (HDAC) 1 and 2 is recruited to the NRE-beads upon
T3 addition, but HDAC1 was observed on NRE even in the
absence of ligand. Contrarily, in the same study [15], using gel
shift assay the authors observed that recombinant rTRb1 could
bind to NRE in a ligand-independent manner. The authors
attributed this discrepancy to another factor postulated to be
present in the extracts that can confer ligand-dependent binding of
TR to the NRE. In accordance with the gel shift assay in this
previous study, our findings show that unliganded TR binds to
NRE. However, contrary to the results that suggested that
endogenous liganded TR binds tightly to NRE, we observed that
T3 attenuates TR-NRE interaction.
Conflicting with the hypothesis that T3 induces recruitment of
TR to the NRE, Matsushita et al. [16] demonstrated that the
negative regulation by liganded TR was preserved after complete
destruction of the NRE, suggesting that this region is not required
for the TSHb down-regulation. In line with this, our results
showing that T3 weakens TR binding to NRE may suggest that
liganded TR may be displaced to another response element for
which TR has higher affinity. Nevertheless, if unliganded TR
binds to NRE, it is reasonable to consider that unligaded TR on
NRE would be a major factor for TSHb transcriptional up-
regulation. However, there is strong in vivo evidence that conflict
with the hypothesis that unligaded TR is involved in TSHb gene
up-regulation: i) TR-knockout mice over-produce thyroid hor-
mones and thyroid stimulating hormone, indicating that activa-
tor(s) other than unliganded TR may be important for TSHb
transcriptional activation [41,44]; ii) later analysis reported that
unliganded TR is not a transcriptional activator for the TSHb
gene and that the major transcriptional activators for the TSHb
gene are Pit1 and GATA2 [16,45–47]. Collectively, these indicate
that unliganded TR is not involved in the TSHb gene activation.
In spite of that, we cannot exclude the hypothesis that NRE could
function as a reservoir for unliganded TR, which would be readily
available to act as a repressor when T3 is present. In the
Matsushita et al. study [16], the need of NRE as a reservoir for
unliganded TR could have been masked by the over expression of
TR in the transient co-transfected cells. Therefore, it would be
important to verify this last hypothesis using cell-based assays, such
as chromatin IP, working with endogenous levels of receptors, or
using mice models with different mutations in the TSHb
promoter.
Studies on the prokaryotic mutant Lac repressor show that a
mutant repressor down-regulates lac genes only in the presence of
lactose (inducer). The inducer weakens the protein-DNA binding,
rendering the mutant capable of freeing itself from non-specific
DNA binding to the lac operator [48]. Similar to this prokaryotic
example, T3 may induce the displacement of TR from the NRE to
other regulatory elements with higher affinity.
DNA binding of the TR-GATA2 in a hormone-dependent
manner
Herein, we have focused our studies on the previously described
TR-GATA2 complex [16], which is the first assembled complex
shown to be responsible for the down-regulation of the TSHb gene
when it is in the presence of T3. It was proposed that the
interaction of the Zn-finger region of GATA2 with the TR DBD
would be sufficient to drive TSHb down-regulation.
Using different purification approaches, gel filtration and anion
exchange column, we could not isolate the potential heterodimer
complex, TR DBD and GATA2-Zf plus DNA. We observed that
both domains could bind independently to a GATA-RE in the
TSHb promoter but could not form a stable heterodimeric
complex on the DNA. Our data confirmed previous results [16]
that TR DL and DBD interact with GATA2-Zf, but we showed
that the affinity of TR for GATA2 is in the low micromolar range.
Interestingly, TR DL bound slightly stronger to GATA2-Zf than
TR DBD. This suggests that the LBD may play a role in this
interaction. This phenomenon was also supported by the
observation that T3/TR has a pronounced effect on GATA2
affinity for GATA-REs.
We showed that the affinity of TR-GATA2-Zf complex for
GATA-RE is dependent on T3, i.e., T3 dramatically increased the
affinity of TR-GATA2-Zf for GATA-RE in the TSHb promoter.
Importantly, to our knowledge these results show for the first time
the hormone-dependent effect on affinity of a heterologous DNA
binding transcription factor.
The fact that the T3/TR-GATA2 complex assembled leads to
TSHb down-regulation and that T3 increases the affinity of TR-
GATA2-Zf for GATA-RE in the TSHb promoter suggest that the
TSHb transcriptional down-regulation may be correlated with the
TR ligand-dependent enhancement of TR-GATA2 affinity for
DNA.
Indeed, studies carried out on S. cerevisiae phosphate response
(PHO) gene drew attention to the correlation between DNA-
binding affinity and transcriptional response. In attempt to test the
hypothesis that chromatin may influence gene expression by
differentially regulating the accessibility of Pho4 transcription
factor sites in the PHO promoter, the authors introduced a series
of variants of this promoter into haploid S.cerevisiae. This pro-
moter contained different affinity Pho4 sites controlling transcrip-
tion of a green fluorescent protein (GFP) reporter gene [49]. The
authors suggested that the interplay of chromatin and binding-site
affinity provides a mechanism for fine-tuning responses to the
same cellular state.
In future work it would be of great significance to verify whether
the increase of DNA-binding affinity of GATA2 by liganded TR
directly correlates with TSHb gene down-regulation in a chro-
matin context.
Theoretical Model
Based on kinetic principles imposed by fluctuation of protein
concentrations in the cell and the different affinities of these
proteins to cooperatively bind to DNA, a simplified model (Fig. 7)
could explain the TR and GATA2 state in the TSHb gene down-
regulation by thyroid hormone. In our model, we speculate that
the unliganded TR may occupy the NRE, whilst GATA2 is on
GATA-RE during the basal up-regulation. The presence of
thyroid hormone, T3, weakens TR-DNA binding facilitating TR
interactions with GATA2. In turn, the complex T3/TR-GATA2
has high affinity to GATA-RE, favouring an on-DNA mechanism.
Therefore, the displacement of the liganded TR from NRE to
another response element would be critical for the mechanism
used by the cell to down-regulate TSHb gene transcription.
In summary, we showed the equilibrium binding of TR to
different regulatory elements present in the TSHb promoter,
providing a catalogue of binding affinities of TR and GATA-Zf to
several enhancer elements. We observed that the ligand T3
weakens the binding of TR to NRE present in TSHb promoter.
Moreover, our data shows that T3/TR-GATA2 complex binds
tightly to different GATA-RE, corroborating previous in vivo data
that suggests this complex plays an important role for gene down-
regulation in an on-DNA mechanism. Importantly, these results
indicate that TR complex formation enhances DNA binding of the
TR and GATA2 on TSH Promoter
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GATA2 and TR occurs through the conserved DNA binding
domain, this mechanism may also be extended to other members
of the nuclear receptor and GATA families.
Our data extend previous results obtained in vivo, further
improving our understanding of how liganded nuclear receptors
down-regulate gene transcription, with the cooperative binding
between transcription factors and DNA forming the core of this
process.
Materials and Methods
Protein Expression and Purification
The human TRb1DAB (TR DBD-LBD or DL) construct
which encodes amino acid residues 102 to 461 and the human
TRb1DAB/EF (TR DBD) construct that encompasses amino
acid residues 102 to 198 fused in frame to the C-terminus of a
poly-histidine (his) tag were expressed in the Escherichia coli strain
BL21(DE3) using a pET28a(+) plasmid (Novagen). The modified
expression and purification protocols were applied as described
[2]. To produce the holo form of the receptor (TR+T3), we
added T3 in 3 times molar excess (3 parts of T3 : 1 part of TR,
molar concentration) and incubated the sample for 1 to 3 hour
at 4uC. After incubation the TR+T3 sample was concentrated
to 400uM and used as a stock protein solution for all the
experiments.
The RXRa1DAB (DBD-LBD or DL) construct which encodes
amino acid residues 126 to 462 fused in frame to the C-terminus of
a poly-histidine (his) tag was expressed in the Escherichia coli strain
BL21(DE3) using a pET28a(+) plasmid (Novagen). The modified
expression and purification protocols were applied as described
[50]. The heterodimer TR-RXR was prepared mixing equimolar
quantities of each protein (1RXR: 1TR+T3, molar concentra-
tion) followed by purification of the complex on a gel filtration
Superdex75 10/30 column (GE Healthcare). The eluted protein
was checked by non-denaturing gel electrophoresis, in order to
verify that only the dimer was present.
Full-length nuclear receptors are notoriously difficult to ex-
press and purify. Currently we are unable to express and purify
the full-length TR construct as a soluble protein in significant
amounts, and therefore we conducted our studies based on TR
DBD and TR DBD-LBD (DL) constructs. It is important to
mention that bacterially expressed TR DL fully reproduces the
DNA binding and oligomerization properties of full length TR
[2,51].
The zinc finger region of GATA2 (GATA2 – Zf) encoding residues
291–412 was cloned from Image Clone (AU96-d11) GeneService
into a pET31a (Novagen). It was expressed in the E.coli strain BL21
(DE3) codon plus using pet 28a (+) plasmid. A Luria Broth (LB)
starter culture was inoculated with a single colony of a LB-agar
culture and grown overnight at 37uC .T h ei n i t i a lc u l t u r ew a s
inoculated at 1–5% into a larger 2XYT culture (1,6% bacto-tryptone,
1% yeast extract, 0.5% NaCl -w/v) grown at 37uC for 10h, induced
with 0.5mM IPTG plus 10mM ZnSO4 and grow for further 6h. The
induced cultures were harvested by centrifugation and pellets were
ressuspended in 50mM Tris-HCl, pH8, 500mM NaCl, 1%Triton x-
100, 2mM b-mercaptoethanol, 10% glycerol, 10uM ZnCl2 and
3mM DTT. The lysate was sonicated and centrifugated at 18000rpm
for 1h, in a Sorvall SS34 rotor at 4uC. The supernatant was loaded
onto Talon Superflow Metal Affinity Resin (Clontech) and was
incubated for 1h at 4uC. The resin was washed in 50mM Tris-HCL,
pH8.0, 300mM NaCl, 20mM imidazol, 2mM b-mercaptoethanol,
10% glycerol and 10uM ZnCl2 for 20cv; and the bound protein was
eluted with 50mM Tris-HCL, pH8.0, 150mM NaCl, 250mM
imidazol, 2mM b-mercaptoethanol and 10% glycerol. The eluted
fraction was incubated with thrombin protease for 18h at 18uC. The
protein was then applied to a superdex75 10/30 gel filtration column
(GE Healthcare) pre-equilibrated with 20mM Hepes, pH8.0,
200mM NaCl, 10% glycerol and 3mM DTT, in order to buffer
exchange. The TR-GATA2-Zf complex was prepared mixing
equimolar quantities of each protein and then the complex was
applied to a gel filtration superdex75 10/30 column. The eluted
fractions were checked by non-denaturing gel electrophoresis, in
order to verify complex formation.
The labeled GATA2-Zf containing an activated fluorescein
molecule was prepared by incubating the protein and the probe,
fluorescein-isothiocianate, in three times molar excess, for 4 hours
at 10uC. The protein-probe complex was applied to a HiTrap
desalting column (GE Healthcare), to separate the excess
fluorescein from the GATA-2-fluorescein complex.
Synthetic Oligonucleotides
The single-stranded synthetic oligonucleotides required for
DNA binding studies synthesized by Sigma or Eurogenetec S.A.
with an attached fluorescein molecule at the 59 of the sense single-
strand were high pressure liquid chromatography-purified.
Oligonucleotides used for fluorescence anisotropy were labelled
on the 59 end of the forward strand with fluorescein-isothiociante
(FITC). Only the forward DNA strand was labelled in order to
avoid energy transfer between fluorophores.
The single stranded oligonucleotides, TSHb NRE -5 9-T GG-
GTCACCACAGCATCTGCTCACCAATGCAAAGT-39, DR4
TRE -5 9- AGTTCAGGTCACAGGAGGTCAGAG- 39, TSHb
GATA-RE -59- TCAATAGATGCTTTTCAGATAAGAA-39,
GATA-RE-5 9- CACTTGATAACAGAAAGTGATAACTCT -
39, were paired with the complementary strand. Oligonucleotides
Figure 7. Theoretical model for TR and GATA2 state in TSHb
gene down regulation by thyroid hormone. Beside the fact that
TR is not believed to participate in the up-regulation of TSHb, the NRE
may be used as a reservoir for TR, leaving the main activators, GATA2
(and, as described, Pit1), to drive gene transcription. Upon T3 binding,
TR is released from NRE, favouring its translocation and interaction with
GATA2-Zf on GATA-RE. The T3/TR-GATA2 complex formation is the
principal complex responsible for the TSHb gene down regulation.
doi:10.1371/journal.pone.0012628.g007
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mable thermocycler, Perkin-Elmer, USA) at equimolar concen-
trations in water, by heating at 100uC for 10 min and slowly
cooled to 25uC. Annealed oligonucleotides were stored in water at
220uC. DNA concentrations were measured by A260 (1A260Z50
mg/ml dsDNA) and at A490 nm (fluorescein, 3490Z65,000 MK1
cmK1).
Electrophoretic analysis of TR DBD and GATA2-Zf on
GATA-RE fractions purified from gel filtration
In order to analyse a potential complex formation of TR DBD
and GATA2-Zf on the TSH GATA-RE, the proteins alone or the
heterodimer TR DBD-GATA2-Zf were prepared by mixing
equimolar quantities (100uM) of each protein plus DNA. After,
an additional size exclusion purification was performed using a
Superdex 75 26/60 column preparative gel filtration column in
10 mM Tris-HCl pH 8, 100 mM NaCl, 5% Glycerol and 3mM
DTT, or 16PBS, 1% Triton 100, 3mM DTT, 10uM ZnCl2.
Fractions from gel filtration containing TR DBD-DNA,
GATA2-DNA, or TR DBD- GATA2-Zf-DNA were run in
agarose gel 1.3% with 0.56TBE. The gel was stained with
Ethidium bromide and analysed using UV light.
Purification of GST-TR DBD, His GATA2-Zf, and GATA-RE
using ion exchange column
The human TRb1DAB/EF (TR DBD) construct that encom-
passes amino acid residues 102 to 198 was cloned into a pGEX
vector (GE Healthcare). The sequence was fused in frame to the
C-terminus of a GST tag and expressed as described above. In
order to isolate the described complex, equimolar quantities
(100uM) of both GST-TR DBD and His-GATA2-Zf in the
presence or absence of DNA were purified using a HiTrap TM SP
FF ion exchange column (Pharmacia Biotech). A gradient was
performed using phosphate buffer pH 6.8, 2mM DTT, 1%
glycerol, and 0.1M – 2M NaCl, at a flow rate of 5mL/min. The
eluted fractions were analysed by SDS-PAGE.
Fluorescence Anisotropy. Isothermal DNA binding assays
with the TR and GATA-2 were carried out using an ISS-PC1
spectrofluorimeter (ISS, Champaign, IL), assembled in ‘‘L’’
geometry. Excitation was set to 480 nm, and emission at
520 nm was recorded through an orange short wave cut-off
filter OG515 (cut-off 50% at 515 nm). Anisotropy values were
calculated as described in previous studies [38]. All fluorescence
anisotropy data shown in this study are an average of at least three
independent experiments, performed with different protein
batches and at different times.
Titrimetric Assay of Protein – DNA Interaction. Iso-
thermal assays of DNA binding to TR DBD-LBD, RXR DBD-
LBD, TR+RXR DBD-LBD, GATA-2, TR+GATA-2 were
performed by titrating a fixed amount of DNA-FITC (10nM)
with varying amount of protein, in a concentration range of 1nM
to 10.000nM (concentrations expressed as monomers in case of
TR, RXR and GATA and in oligomeric form in case of
heterodimer TR+RXR or GATA-2+TR complex). In all cases,
maximal dilution was less than 20%. Changes in fluorescence
intensity and in the DNA or protein concentrations were corrected
for dilution. Binding reactions were carried out at 10uC in 50mM
NaCl, 20mM Hepes pH8.0, 3mM dithiothreitol, 5% glycerol.
These assays were made in presence of 1mM MgCl2 to avoid non-
specific binding. The protein-DNA interaction isotherms were
analyzed considering, firstly, a simple two-state reversible
equilibrium between protein and DNA, and, secondly, using the
Hill approach. The dissociation constant Kd of the above reaction
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where a is the fraction of bound DNA, Aobs is the observed
anisotropy at total monomeric protein concentration PT, and Ai
and Af are, respectively, the lower and upper asymptotic limits for
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where n is the Hill cooperativity coefficient [52]. No corrections were
applied to quantum yields since no significant changes in fluorescence
intensity occur through the binding curves. All equations were
adjusted to the data by nonlinear least-squares regression using
SigmaPlot 2006 (version 10.0, Jandel Scientific Co.).
Titrimetric Assay of Protein – Protein Interaction. These
assays were performed in order to analyze a potential interaction
between TR and GATA-2 [16]. Isotherm binding assays were
performed by incubating 10nM of fluorescein-labeled GATA2-Zf
with unlabeled TR DBD-LBD or TR DBD in the concentration
ranging from 1nM to 10.000nM. The assays were performed at
10uC in 50mM NaCl, 20mM Hepes pH8.0, 3mM dithiothreitol,
5% glycerol. TR-GATA-2 binding assays were analyzed
considering the simple two-state reversible equilibrium between
TR as described elsewhere [53].
High Nuclear Receptor concentration in low salt conditions
favours nonspecific binding to DNA [54], imposing a limitation of
finding a second plateau in fluorescence anisotropy assays. Here
the concentrations of NRs were kept below 10uM to avoid
nonspecific binding titration analyse. In order to better define the
second plateau of DNA saturation, measurements indicating
nonspecific binding were ignored and the last binding point was
repeated 3 times at its original concentration, thus fixing the
second plateau and allowing Kds to be recalculated. The Kd
values did not change significantly and the errors referring to Kd
determinations were lower than the first approach. In this way, we
confirmed the first Kd values and achieved our second plateau.
Acknowledgments
We are grateful to John Schwabe and Daniela Rhodes for the insightful
discussions. We also thank the anonymous reviewers for the important
comments and suggestions on the manuscript, and Lynda Chapman and





TR and GATA2 on TSH Promoter
PLoS ONE | www.plosone.org 8 September 2010 | Volume 5 | Issue 9 | e12628Author Contributions
Conceived and designed the experiments: ACMF GMS. Performed the
experiments: ACMF GMS. Analyzed the data: ACMF IP DV GMS.
Contributed reagents/materials/analysis tools: IP DV GMS. Wrote the
paper: GMS.
References
1. Kersten S, Kelleher D, Chambon P, Gronemeyer H, Noy N (1995) Retinoid X
receptor alpha forms tetramers in solution. Proc Natl Acad Sci U S A 92:
8645–8649.
2. Figueira AC, Dias SM, Santos MA, Apriletti JW, Baxter JD, et al. (2006) Human
thyroid receptor forms tetramers in solution, which dissociate into dimers upon
ligand binding. Cell Biochem Biophys 44: 453–462.
3. Weitzel JM, Radtke C, Seitz HJ (2001) Two thyroid hormone-mediated gene
expression patterns in vivo identified by cDNA expression arrays in rat. Nucleic
Acids Res 29: 5148–5155.
4. Flores-Morales A, Gullberg H, Fernandez L, Stahlberg N, Lee NH, et al. (2002)
Patterns of liver gene expression governed by TRbeta. Mol Endocrinol 16:
1257–1268.
5. Weitzel JM, Hamann S, Jauk M, Lacey M, Filbry A, et al. (2003) Hepatic gene
expression patterns in thyroid hormone-treated hypothyroid rats. J Mol
Endocrinol 31: 291–303.
6. Feng X, Jiang Y, Meltzer P, Yen PM (2000) Thyroid hormone regulation of
hepatic genes in vivo detected by complementary DNA microarray. Mol
Endocrinol 14: 947–955.
7. Weitzel JM (2008) To bind or not to bind - how to down-regulate target genes by
liganded thyroid hormone receptor? Thyroid Res 1: 4.
8. Chatterjee VK, Lee JK, Rentoumis A, Jameson JL (1989) Negative regulation of
the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor
interaction adjacent to the TATA box. Proc Natl Acad Sci U S A 86:
9114–9118.
9. Wondisford FE, Farr EA, Radovick S, Steinfelder HJ, Moates JM, et al. (1989)
Thyroid hormone inhibition of human thyrotropin beta-subunit gene expression
is mediated by a cis-acting element located in the first exon. J Biol Chem 264:
14601–14604.
10. Chin WW, Carr FE, Burnside J, Darling DS (1993) Thyroid hormone regulation
of thyrotropin gene expression. Recent Prog Horm Res 48: 393–414.
11. Wondisford FE, Steinfelder HJ, Nations M, Radovick S (1993) AP-1 antagonizes
thyroid hormone receptor action on the thyrotropin beta-subunit gene. J Biol
Chem 268: 2749–2754.
12. Carr FE, Kaseem LL, Wong NC (1992) Thyroid hormone inhibits thyrotropin
gene expression via a position-independent negative L-triiodothyronine-
responsive element. J Biol Chem 267: 18689–18694.
13. Darling DS, Burnside J, Chin WW (1989) Binding of thyroid hormone receptors
to the rat thyrotropin-beta gene. Mol Endocrinol 3: 1359–1368.
14. Carr FE, Wong NC (1994) Characteristics of a negative thyroid hormone
response element. J Biol Chem 269: 4175–4179.
15. Sasaki S, Lesoon-Wood LA, Dey A, Kuwata T, Weintraub BD, et al. (1999)
Ligand-induced recruitment of a histone deacetylase in the negative-feedback
regulation of the thyrotropin beta gene. Embo J 18: 5389–5398.
16. Matsushita A, Sasaki S, Kashiwabara Y, Nagayama K, Ohba K, et al. (2007)
Essential role of GATA2 in the negative regulation of thyrotropin beta gene by
thyroid hormone and its receptors. Mol Endocrinol 21: 865–884.
17. Shibusawa N, Hollenberg AN, Wondisford FE (2003) Thyroid hormone
receptor DNA binding is required for both positive and negative gene
regulation. J Biol Chem 278: 732–738.
18. Shibusawa N, Hashimoto K, Nikrodhanond AA, Liberman MC, Applebury ML,
et al. (2003) Thyroid hormone action in the absence of thyroid hormone
receptor DNA-binding in vivo. J Clin Invest 112: 588–597.
19. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, et al. (1998)
DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:
531–541.
20. Herrlich P (2001) Cross-talk between glucocorticoid receptor and AP-1.
Oncogene 20: 2465–2475.
21. De Bosscher K, Vanden Berghe W, Haegeman G (2006) Cross-talk between
nuclear receptors and nuclear factor kappaB. Oncogene 25: 6868–6886.
22. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, et al. (1990)
Functional antagonism between oncoprotein c-Jun and the glucocorticoid
receptor. Cell 62: 1217–1226.
23. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, et al. (1990)
Transcriptional interference between c-Jun and the glucocorticoid receptor:
mutual inhibition of DNA binding due to direct protein-protein interaction. Cell
62: 1205–1215.
24. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, et al. (1997) I
kappaB alpha-independent downregulation of NF-kappaB activity by glucocor-
ticoid receptor. Embo J 16: 4698–4707.
25. Clabby ML, Robison TA, Quigley HF, Wilson DB, Kelly DP (2003) Retinoid X
receptor alpha represses GATA-4-mediated transcription via a retinoid-
dependent interaction with the cardiac-enriched repressor FOG-2. J Biol Chem
278: 5760–5767.
26. Tsuzuki S, Kitajima K, Nakano T, Glasow A, Zelent A, et al. (2004) Cross talk
between retinoic acid signaling and transcription factor GATA-2. Mol Cell Biol
24: 6824–6836.
27. Magklara A, Smith CL (2009) A composite intronic element directs dynamic
binding of the progesterone receptor and GATA-2. Mol Endocrinol 23: 61–
73.
28. Xu Z, Yu S, Hsu CH, Eguchi J, Rosen ED (2008) The orphan nuclear receptor
chicken ovalbumin upstream promoter-transcription factor II is a critical
regulator of adipogenesis. Proc Natl Acad Sci U S A 105: 2421–2426.
29. Nagayama K, Sasaki S, Matsushita A, Ohba K, Iwaki H, et al. (2008) Inhibition
of GATA2-dependent transactivation of the TSHbeta gene by ligand-bound
estrogen receptor alpha. J Endocrinol 199: 113–125.
30. Bhardwaj A, Rao MK, Kaur R, Buttigieg MR, Wilkinson MF (2008) GATA
factors and androgen receptor collaborate to transcriptionally activate the
Rhox5 homeobox gene in Sertoli cells. Mol Cell Biol 28: 2138–2153.
31. Ko LJ, Engel JD (1993) DNA-binding specificities of the GATA transcription
factor family. Mol Cell Biol 13: 4011–4022.
32. Martin DI, Orkin SH (1990) Transcriptional activation and DNA binding by the
erythroid factor GF-1/NF-E1/Eryf 1. Genes Dev 4: 1886–1898.
33. Andersson ML, Nordstrom K, Demczuk S, Harbers M, Vennstrom B (1992)
Thyroid hormone alters the DNA binding properties of chicken thyroid
hormone receptors alpha and beta. Nucleic Acids Res 20: 4803–4810.
34. Velasco LF, Togashi M, Walfish PG, Pessanha RP, Moura FN, et al. (2007)
Thyroid hormone response element organization dictates the composition of
active receptor. J Biol Chem 282: 12458–12466.
35. Miyamoto T, Suzuki S, DeGroot LJ (1993) High affinity and specificity of
dimeric binding of thyroid hormone receptors to DNA and their ligand-
dependent dissociation. Mol Endocrinol 7: 224–231.
36. Kurokawa R, Yu VC, Naar A, Kyakumoto S, Han Z, et al. (1993) Differential
orientations of the DNA-binding domain and carboxy-terminal dimerization
interface regulate binding site selection by nuclear receptor heterodimers. Genes
Dev 7: 1423–1435.
37. Desvergne B (1994) How do thyroid hormone receptors bind to structurally
diverse response elements? Mol Cell Endocrinol 100: 125–131.
38. Figueira AC, Lima LM, Lima LH, Ranzani AT, Mule Gdos S, et al. (2010)
Recognition by the thyroid hormone receptor of canonical DNA response
elements. Biochemistry 49: 893–904.
39. Conti E, Rhodes D (2009) Modern times: not for the faint-hearted. Curr Opin
Struct Biol 19: 62–64.
40. Lonard DM, O’Malley BW (2008) SRC-3 transcription-coupled activation,
degradation, and the ubiquitin clock: is there enough coactivator to go around in
cells? Sci Signal 1: pe16.
41. Barros AC, Erway LC, Krezel W, Curran T, Kastner P, et al. (1998) Absence of
thyroid hormone receptor beta-retinoid X receptor interactions in auditory
function and in the pituitary-thyroid axis. Neuroreport 9: 2933–2937.
42. Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, et al. (2008) Structure
of the intact PPAR-gamma-RXR-alpha nuclear receptor complex on DNA.
Nature 29: 350–356.
43. Cohen O, Flynn TR, Wondisford FE (1995) Ligand-dependent antagonism by
retinoid X receptors of inhibitory thyroid hormone response elements. J Biol
Chem 270: 13899–13905.
44. Gothe S, Wang Z, Ng L, Kindblom JM, Barros AC, et al. (1999) Mice devoid of
all known thyroid hormone receptors are viable but exhibit disorders of the
pituitary-thyroid axis, growth, and bone maturation. Genes Dev 13: 1329–1341.
45. Nakano K, Matsushita A, Sasaki S, Misawa H, Nishiyama K, et al. (2004)
Thyroid-hormone-dependent negative regulation of thyrotropin beta gene by
thyroid hormone receptors: study with a new experimental system using CV1
cells. Biochem J 378: 549–557.
46. Gordon DF, Lewis SR, Haugen BR, James RA, McDermott MT, et al. (1997)
Pit-1 and GATA-2 interact and functionally cooperate to activate the
thyrotropin beta-subunit promoter. J Biol Chem 272: 24339–24347.
47. Dasen JS, O’Connell SM, Flynn SE, Treier M, Gleiberman AS, et al. (1999)
Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced
determination of pituitary cell types. Cell 97: 587–598.
48. Schmitz A, Coulondre C, Miller JH (1978) Genetic studies of the lac repressor.
V. Repressors which bind operator more tightly generated by suppression and
reversion of nonsense mutations. J Mol Biol 123: 431–454.
49. Lam FH, Steger DJ, O’Shea EK (2008) Chromatin decouples promoter
threshold from dynamic range. Nature 453: 246–250.
50. Fischer H, Dias SM, Santos MA, Alves AC, Zanchin N, et al. (2003) Low
resolution structures of the retinoid X receptor DNA-binding and ligand-binding
domains revealed by synchrotron X-ray solution scattering. J Biol Chem 278:
16030–16038.
51. Ribeiro RC, Kushner PJ, Apriletti JW, West BL, Baxter JD (1992) Thyroid
hormone alters in vitro DNA binding of monomers and dimers of thyroid
hormone receptors. Mol Endocrinol 6: 1142–1152.
52. Lima LM, Silva JL (2004) Positive contribution of hydration on DNA binding by
E2c protein from papillomavirus. J Biol Chem 279: 47968–47974.
TR and GATA2 on TSH Promoter
PLoS ONE | www.plosone.org 9 September 2010 | Volume 5 | Issue 9 | e1262853. Matozo HC, Santos MA, de Oliveira Neto M, Bleicher L, Lima LM, et al.
(2007) Low-resolution structure and fluorescence anisotropy analysis of protein
tyrosine phosphatase eta catalytic domain. Biophys J 92: 4424–4432.
54. Ozers MS, Hill JJ, Ervin K, Wood JR, Nardulli AM, et al. (1997) Equilibrium
binding of estrogen receptor with DNA using fluorescence anisotropy. J Biol
Chem 272: 30405–30411.
TR and GATA2 on TSH Promoter
PLoS ONE | www.plosone.org 10 September 2010 | Volume 5 | Issue 9 | e12628